Compare $SRPT vs $VCEL | Chartloom

Compare

$SRPT vs $VCEL

Sarepta Therapeutics Inc · Vericel Corp

SRPT

Sarepta Therapeutics Inc

VCEL

Vericel Corp

Compare $SRPT vs $VCEL

Comparing Sarepta Therapeutics Inc and Vericel Corp

SRPTSarepta Therapeutics Inc

VCELVericel Corp

SRPTSarepta Therapeutics Inc

Market cap

$1.88B

P/E (TTM)

—

Forward P/E (NTM)

46.80x

Forward P/S (NTM)

1.31x

Rev growth (TTM)

-20.4%

YTD performance

-16.2%

52W performance

-23.7%

FCF yield

4.0%

VCELVericel Corp

Market cap

$2.05B

P/E (TTM)

86.61x

Forward P/E (NTM)

55.49x

Forward P/S (NTM)

5.56x

Rev growth (TTM)

23.0%

YTD performance

12.6%

52W performance

17.5%

FCF yield

3.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

SRPT

VCEL

Detailed metrics comparison

SRPT

Sarepta Therapeutics Inc

VCEL

Vericel Corp

Market Cap

SRPT$1.88B

VCEL$2.05B

Enterprise Value

SRPT$2.16B

VCEL$1.92B

Price

SRPT$17.85

VCEL$40.10

P/E Ratio

SRPTN/A

VCEL86.61x

P/S Ratio

SRPT0.95x

VCEL6.69x

EV/Sales

SRPT1.09x

VCEL6.28x

EV/EBITDA

SRPT12.13x

VCEL58.45x

P/B Ratio

SRPT1.21x

VCEL5.56x

P/FCF Ratio

SRPT25.00x

VCEL33.21x

EV/FCF

SRPT28.66x

VCEL31.19x

PEG Ratio

SRPTN/A

VCEL0.32x

Forward P/E (NTM)

SRPT46.80x

VCEL55.49x

Forward P/S (NTM)

SRPT1.31x

VCEL5.56x

Revenue (TTM)

SRPT$1.97B

VCEL$306M

Revenue Growth (YoY)

SRPT-20.4%

VCEL23.0%

Forward Rev Growth

SRPT-23.2%

VCEL16.9%

Gross Margin (TTM)

SRPT67.5%

VCEL74.6%

Operating Margin (TTM)

SRPT0.0%

VCEL6.0%

EBITDA Margin (TTM)

SRPT7.5%

VCEL10.2%

Net Margin (TTM)

SRPT-6.9%

VCEL7.9%

FCF Margin (TTM)

SRPT3.8%

VCEL20.1%

Net Income (TTM)

SRPT$-137M

VCEL$24M

FCF (TTM)

SRPT$75M

VCEL$62M

EPS (TTM)

SRPT-$1.30

VCEL$0.46

ROE (TTM)

SRPT-996.0%

VCEL6.9%

ROA (TTM)

SRPT-414.0%

VCEL5.0%

ROIC (TTM)

SRPT-605.0%

VCEL6.9%

Cash

SRPT$571M

VCEL$125M

Debt

SRPT$848M

VCEL$596K

Net Cash/Debt

SRPT$-276M

VCEL$125M

Current Ratio (TTM)

SRPT4.42x

VCEL5.04x

Quick Ratio (TTM)

SRPT2.57x

VCEL4.69x

Debt/Equity (TTM)

SRPT0.55x

VCEL0.00x

Debt/Assets (TTM)

SRPT0.0%

VCEL0.0%

Interest Coverage (TTM)

SRPTN/A

VCELN/A

Net Debt/EBITDA (TTM)

SRPT0.00x

VCEL0.00x

Beta

SRPT0.46

VCEL1.06

52W Performance

SRPT-23.7%

VCEL17.5%

YTD Performance

SRPT-16.2%

VCEL12.6%

% from 52W High

SRPT-27.7%

VCEL-18.7%

% from 52W Low

SRPT21.6%

VCEL38.5%

Asset Turnover (TTM)

SRPT0.60x

VCEL0.63x

FCF Yield (TTM)

SRPT4.0%

VCEL3.0%

Earnings Yield (TTM)

SRPT-7.3%

VCEL1.2%

Dividend Yield (TTM)

SRPTN/A

VCELN/A

Rule of 40

SRPT-16.6

VCEL43.1

EV/GP/RG

SRPTN/A

VCEL0.39

Ticker research

View SRPT research View VCEL research

Metric	SRPT Sarepta Therapeutics Inc	VCEL Vericel Corp
Market & Valuation
Market Cap	$1.88B	$2.05B
Enterprise Value	$2.16B	$1.92B
Price	$17.85	$40.10
P/E Ratio	N/A	86.61x
P/S Ratio	0.95x	6.69x
EV/Sales	1.09x	6.28x
EV/EBITDA	12.13x	58.45x
P/B Ratio	1.21x	5.56x
P/FCF Ratio	25.00x	33.21x
EV/FCF	28.66x	31.19x
PEG Ratio	N/A	0.32x
Forward P/E (NTM)	46.80x	55.49x
Forward P/S (NTM)	1.31x	5.56x
Revenue & Growth
Revenue (TTM)	$1.97B	$306M
Revenue Growth (YoY)	-20.4%	23.0%
Forward Rev Growth	-23.2%	16.9%
Profitability
Gross Margin (TTM)	67.5%	74.6%
Operating Margin (TTM)	0.0%	6.0%
EBITDA Margin (TTM)	7.5%	10.2%
Net Margin (TTM)	-6.9%	7.9%
FCF Margin (TTM)	3.8%	20.1%
Net Income (TTM)	$-137M	$24M
FCF (TTM)	$75M	$62M
EPS (TTM)	-$1.30	$0.46
ROE (TTM)	-996.0%	6.9%
ROA (TTM)	-414.0%	5.0%
ROIC (TTM)	-605.0%	6.9%
Financial Health
Cash	$571M	$125M
Debt	$848M	$596K
Net Cash/Debt	$-276M	$125M
Current Ratio (TTM)	4.42x	5.04x
Quick Ratio (TTM)	2.57x	4.69x
Debt/Equity (TTM)	0.55x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.46	1.06
52W Performance	-23.7%	17.5%
YTD Performance	-16.2%	12.6%
% from 52W High	-27.7%	-18.7%
% from 52W Low	21.6%	38.5%
Efficiency & Yields
Asset Turnover (TTM)	0.60x	0.63x
FCF Yield (TTM)	4.0%	3.0%
Earnings Yield (TTM)	-7.3%	1.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-16.6	43.1
EV/GP/RG	N/A	0.39
Ticker research	View SRPT research	View VCEL research

Valuation

P/E Ratio

VCEL

86.61x

P/S Ratio

SRPT

0.95x

VCEL

6.69x

EV/FCF

SRPT

28.66x

VCEL

31.19x

Growth & revenue

Revenue Growth TTM

VCEL

23.0%

SRPT

-20.4%

Forward Revenue Growth

VCEL

16.9%

SRPT

-23.2%

Profitability & performance

Gross Margin

VCEL

74.6%

SRPT

67.5%

ROE

VCEL

6.9%

SRPT

-996.0%

FCF Yield %

SRPT

4.0%

VCEL

3.0%

52-Week Performance

VCEL

17.5%

SRPT

-23.7%

Detailed metrics comparison

SRPT

Sarepta Therapeutics Inc

VCEL

Vericel Corp

Market Cap

SRPT$1.88B

VCEL$2.05B

Enterprise Value

SRPT$2.16B

VCEL$1.92B

Price

SRPT$17.85

VCEL$40.10

P/E Ratio

SRPTN/A

VCEL86.61x

P/S Ratio

SRPT0.95x

VCEL6.69x

EV/Sales

SRPT1.09x

VCEL6.28x

EV/EBITDA

SRPT12.13x

VCEL58.45x

P/B Ratio

SRPT1.21x

VCEL5.56x

P/FCF Ratio

SRPT25.00x

VCEL33.21x

EV/FCF

SRPT28.66x

VCEL31.19x

PEG Ratio

SRPTN/A

VCEL0.32x

Forward P/E (NTM)

SRPT46.80x

VCEL55.49x

Forward P/S (NTM)

SRPT1.31x

VCEL5.56x

Revenue (TTM)

SRPT$1.97B

VCEL$306M

Revenue Growth (YoY)

SRPT-20.4%

VCEL23.0%

Forward Rev Growth

SRPT-23.2%

VCEL16.9%

Gross Margin (TTM)

SRPT67.5%

VCEL74.6%

Operating Margin (TTM)

SRPT0.0%

VCEL6.0%

EBITDA Margin (TTM)

SRPT7.5%

VCEL10.2%

Net Margin (TTM)

SRPT-6.9%

VCEL7.9%

FCF Margin (TTM)

SRPT3.8%

VCEL20.1%

Net Income (TTM)

SRPT$-137M

VCEL$24M

FCF (TTM)

SRPT$75M

VCEL$62M

EPS (TTM)

SRPT-$1.30

VCEL$0.46

ROE (TTM)

SRPT-996.0%

VCEL6.9%

ROA (TTM)

SRPT-414.0%

VCEL5.0%

ROIC (TTM)

SRPT-605.0%

VCEL6.9%

Cash

SRPT$571M

VCEL$125M

Debt

SRPT$848M

VCEL$596K

Net Cash/Debt

SRPT$-276M

VCEL$125M

Current Ratio (TTM)

SRPT4.42x

VCEL5.04x

Quick Ratio (TTM)

SRPT2.57x

VCEL4.69x

Debt/Equity (TTM)

SRPT0.55x

VCEL0.00x

Debt/Assets (TTM)

SRPT0.0%

VCEL0.0%

Interest Coverage (TTM)

SRPTN/A

VCELN/A

Net Debt/EBITDA (TTM)

SRPT0.00x

VCEL0.00x

Beta

SRPT0.46

VCEL1.06

52W Performance

SRPT-23.7%

VCEL17.5%

YTD Performance

SRPT-16.2%

VCEL12.6%

% from 52W High

SRPT-27.7%

VCEL-18.7%

% from 52W Low

SRPT21.6%

VCEL38.5%

Asset Turnover (TTM)

SRPT0.60x

VCEL0.63x

FCF Yield (TTM)

SRPT4.0%

VCEL3.0%

Earnings Yield (TTM)

SRPT-7.3%

VCEL1.2%

Dividend Yield (TTM)

SRPTN/A

VCELN/A

Rule of 40

SRPT-16.6

VCEL43.1

EV/GP/RG

SRPTN/A

VCEL0.39

Ticker research

View SRPT research View VCEL research

Metric	SRPT Sarepta Therapeutics Inc	VCEL Vericel Corp
Market & Valuation
Market Cap	$1.88B	$2.05B
Enterprise Value	$2.16B	$1.92B
Price	$17.85	$40.10
P/E Ratio	N/A	86.61x
P/S Ratio	0.95x	6.69x
EV/Sales	1.09x	6.28x
EV/EBITDA	12.13x	58.45x
P/B Ratio	1.21x	5.56x
P/FCF Ratio	25.00x	33.21x
EV/FCF	28.66x	31.19x
PEG Ratio	N/A	0.32x
Forward P/E (NTM)	46.80x	55.49x
Forward P/S (NTM)	1.31x	5.56x
Revenue & Growth
Revenue (TTM)	$1.97B	$306M
Revenue Growth (YoY)	-20.4%	23.0%
Forward Rev Growth	-23.2%	16.9%
Profitability
Gross Margin (TTM)	67.5%	74.6%
Operating Margin (TTM)	0.0%	6.0%
EBITDA Margin (TTM)	7.5%	10.2%
Net Margin (TTM)	-6.9%	7.9%
FCF Margin (TTM)	3.8%	20.1%
Net Income (TTM)	$-137M	$24M
FCF (TTM)	$75M	$62M
EPS (TTM)	-$1.30	$0.46
ROE (TTM)	-996.0%	6.9%
ROA (TTM)	-414.0%	5.0%
ROIC (TTM)	-605.0%	6.9%
Financial Health
Cash	$571M	$125M
Debt	$848M	$596K
Net Cash/Debt	$-276M	$125M
Current Ratio (TTM)	4.42x	5.04x
Quick Ratio (TTM)	2.57x	4.69x
Debt/Equity (TTM)	0.55x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.46	1.06
52W Performance	-23.7%	17.5%
YTD Performance	-16.2%	12.6%
% from 52W High	-27.7%	-18.7%
% from 52W Low	21.6%	38.5%
Efficiency & Yields
Asset Turnover (TTM)	0.60x	0.63x
FCF Yield (TTM)	4.0%	3.0%
Earnings Yield (TTM)	-7.3%	1.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-16.6	43.1
EV/GP/RG	N/A	0.39
Ticker research	View SRPT research	View VCEL research